For the Inventor, By the Inventor

Enter assignee name

Branford, CT, United States of America

Cgi Pharmaceuticals, Inc.

USPTO Granted Patents = 13

EPO Patents = 1

Forward Citations = 345

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

Scott A Mitchell (13 out of 67 patents)

Kevin S Currie (9 out of 72 patents)

Robert W DeSimone (8 out of 34 patents)

4. Douglas A Pippin (7 out of 8 patents)

5. Peter A Blomgren (6 out of 53 patents)

6. James William Darrow (6 out of 16 patents)

7. Jeffrey E Kropf (4 out of 45 patents)

8. Seung H Lee (4 out of 37 patents)

9. Aaron C Schmitt (3 out of 25 patents)

10. Jianjun Xu (3 out of 40 patents)

11. Pavel E Zhichkin (3 out of 14 patents)

12. David R Brittelli (3 out of 20 patents)

13. Zhongdong Zhao (2 out of 32 patents)

14. Mihaela Diana Danca (2 out of 13 patents)

15. Douglas A I Pippin (2 out of 2 patents)

13 patents: Sort by Forward Citations

1. 8426424 - Certain substituted amides, method of making, and method of use thereof (2013-04-23),

2. 7947835 - Certain substituted amides, method of making, and method of use thereof (2011-05-24),

3. 7884108 - Certain substituted pyrazinones (2011-02-08),

4. 7838523 - Certain substituted amides, method of making, and method of use thereof (2010-11-23),

5. 7777040 - Certain substituted ureas, as modulators of kinase activity (2010-08-17),

6. 7625931 - Certain substituted diphenyl ureas, as modulators of kinase activity (2009-12-01),

7. 7405295 - Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds (2008-07-29),

8. 7393848 - Certain heterocyclic substituted imidazo[1,2-A]pyrazin-8-ylamines and methods of inhibition of Bruton's tyrosine kinase by such compounds (2008-07-01),

9. 7312341 - 6-aryl-imidazo[1,2-a] pyrazin-8-ylamines, method of making, and method of use thereof (2007-12-25),

10. 7259164 - Certain substituted imidazo[1,2-a]pyrazines, as modulators of kinase activity (2007-08-21),

11. 7189723 - Certain 8-heteroaryl-6-phenyl-imidazo[1,2-a]pyrazines as modulators of kinase activity (2007-03-13),

12. 7160885 - Certain 6, 8-(heteroaryl or aryl) disubstituted imidazo[1,2-a]pyrazines as modulators of Hsp90 complex activity (2007-01-09),

13. 7015227 - Certain amino-substituted monocycles as kinase modulators (2006-03-21),

CGI Pharmaceuticals, Inc. is a leading biopharmaceutical company specializing in the development and commercialization of innovative medicines. Our mission is to improve the lives of patients through groundbreaking research and advanced drug discovery. With a dedicated team of scientists, we focus on the discovery and development of novel therapeutics for the treatment of various diseases, including cancer, neurological disorders, and autoimmune conditions. Visit our website to learn more about our cutting-edge research and transformative pharmaceutical solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#12 in Branford, CT

#490 in Connecticut

#23,148 in US

#43,688 in the World

Branford, CT, United States of America

Cgi Pharmaceuticals, Inc.

Forward Citations = 345

23 inventors:

Scott A Mitchell (13 out of 67 patents)

Kevin S Currie (9 out of 72 patents)

Robert W DeSimone (8 out of 34 patents)

4. Douglas A Pippin (7 out of 8 patents)

5. Peter A Blomgren (6 out of 53 patents)

Please report any incorrect information to support@idiyas.com

Loading…